ESSEX BIO-TECH (01061) Enters Exclusive Distribution Agreement with OSTEOPORE

Stock News01-15

ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in the field of 3D-printed, bionic, and bio-absorbable implants. Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor for innovative dental, orthodontic, and maxillofacial products in Mainland China, Hong Kong, and Macau. The anticipated contract value of the distribution agreement exceeds RMB 12 million, which includes upfront and milestone payments, with the potential for further additional revenue generated through product procurement and supply. This collaboration with Osteopore marks a significant milestone for the Group in the oral care market, expanding its portfolio of dental, orthodontic, and maxillofacial solutions, and will collectively support the Group's pursuit of sustainable growth in the Chinese market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161915389?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-15 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161915389","market":"nz","top_or_hot":-1,"title":"ESSEX BIO-TECH (01061) Enters Exclusive Distribution Agreement with OSTEOPORE","media":"Stock News","content":"<p>ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in the field of 3D-printed, bionic, and bio-absorbable implants. Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor for innovative dental, orthodontic, and maxillofacial products in Mainland China, Hong Kong, and Macau. The anticipated contract value of the distribution agreement exceeds RMB 12 million, which includes upfront and milestone payments, with the potential for further additional revenue generated through product procurement and supply. This collaboration with Osteopore marks a significant milestone for the Group in the oral care market, expanding its portfolio of dental, orthodontic, and maxillofacial solutions, and will collectively support the Group's pursuit of sustainable growth in the Chinese market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ESSEX BIO-TECH (01061) Enters Exclusive Distribution Agreement with OSTEOPORE</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nESSEX BIO-TECH (01061) Enters Exclusive Distribution Agreement with OSTEOPORE\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-15 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in the field of 3D-printed, bionic, and bio-absorbable implants. Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor for innovative dental, orthodontic, and maxillofacial products in Mainland China, Hong Kong, and Macau. The anticipated contract value of the distribution agreement exceeds RMB 12 million, which includes upfront and milestone payments, with the potential for further additional revenue generated through product procurement and supply. This collaboration with Osteopore marks a significant milestone for the Group in the oral care market, expanding its portfolio of dental, orthodontic, and maxillofacial solutions, and will collectively support the Group's pursuit of sustainable growth in the Chinese market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1161915389","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161915389","pubTimestamp":1768472769,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","01061":"亿胜生物科技"},"translate_title":"亿胜生物(01061)与OSTEOPORE订立独家经销协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in the field of 3D-printed, bionic, and bio-absorbable implants. Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor for innovative dental, orthodontic, and maxillofacial products in Mainland China, Hong Kong, and Macau. The anticipated contract value of the distribution agreement exceeds RMB 12 million, which includes upfront and milestone payments, with the potential for further additional revenue generated through product procurement and supply. This collaboration with Osteopore marks a significant milestone for the Group in the oral care market, expanding its portfolio of dental, orthodontic, and maxillofacial solutions, and will collectively support the Group's pursuit of sustainable growth in the Chinese market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161915389","isCrawlerRequest":true}